Tuesday, September 27, 2011

Deutsche Bank likes Allscripts...

Deutsche Bank pounds the table for Allscripts (MDRX) following meetings with management, touting the company's "attractive valuation and solid growth momentum." The firm also claims Allscripts is already generating over $200M in cross-selling synergies from its acquisition of Eclipsys.

Alscripts is leading the charge of signing up hospitals and doctor's groups to a nationwide healthcare and prescription network, where doctors can access patient's records more easily.  

Here is the long term chart going back to 2004:

No comments: